133 related articles for article (PubMed ID: 32453481)
21. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
[TBL] [Abstract][Full Text] [Related]
22. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
23. Value of surveillance imaging in the management of medulloblastoma.
Yalçin B; Büyükpamukçu M; Akalan N; Cila A; Kutluk MT; Akyüz C
Med Pediatr Oncol; 2002 Feb; 38(2):91-7. PubMed ID: 11813172
[TBL] [Abstract][Full Text] [Related]
24. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
Herrlinger U; Steinbrecher A; Rieger J; Hau P; Kortmann RD; Meyermann R; Schabet M; Bamberg M; Dichgans J; Bogdahn U; Weller M
J Neurol; 2005 Mar; 252(3):291-9. PubMed ID: 16189725
[TBL] [Abstract][Full Text] [Related]
25. The radiation treatment of medulloblastoma.
Jenkin D
J Neurooncol; 1996 Jul; 29(1):45-54. PubMed ID: 8817415
[TBL] [Abstract][Full Text] [Related]
26. Infants with medulloblastoma: a single institution review of survival.
Geyer R; Levy M; Berger MS; Milstein J; Griffin B; Bleyer WA
Neurosurgery; 1991 Nov; 29(5):707-10; discussion 710-1. PubMed ID: 1961400
[TBL] [Abstract][Full Text] [Related]
27. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ
Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043
[TBL] [Abstract][Full Text] [Related]
28. Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication.
Weil AG; Wang AC; Westwick HJ; Ibrahim GM; Ariani RT; Crevier L; Perreault S; Davidson T; Tseng CH; Fallah A
J Neurooncol; 2017 Mar; 132(1):99-107. PubMed ID: 27981412
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma.
Wang C; Yuan XJ; Jiang MW; Wang LF
J Neurosurg Pediatr; 2016 Jan; 17(1):49-56. PubMed ID: 26451721
[TBL] [Abstract][Full Text] [Related]
30. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M
Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018
[TBL] [Abstract][Full Text] [Related]
31. Survival difference between brainstem and cerebellum medulloblastoma: the surveillance, epidemiology, and end results-based study.
Qin Q; Huang D; Jiang Y
Medicine (Baltimore); 2020 Oct; 99(41):e22366. PubMed ID: 33031272
[TBL] [Abstract][Full Text] [Related]
32. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
[TBL] [Abstract][Full Text] [Related]
33. Cerebellar medulloblastomas in adults.
Tekkök IH; Süzer T; Ozgen T; Erbengi A
Neurosurg Rev; 1991; 14(2):135-40. PubMed ID: 1870719
[TBL] [Abstract][Full Text] [Related]
34. [Craniospinal radiotherapy in combined therapy of medulloblastoma in children and adolescents].
Golubicić I; Bokun J; Nikitović M; Mladenović J; Sarić M; Bekić Z
Srp Arh Celok Lek; 2003; 131(5-6):226-31. PubMed ID: 14692129
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of late effects of postoperative radiotherapy in patients with medulloblastoma.
Karadağ O; Demiröz Abakay C; Özkan L; Sağlam H; Demirkaya M
Turk J Pediatr; 2015; 57(2):167-71. PubMed ID: 26690598
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.
Whitton AC; Syndikus I; Tait DM; Bloom HJ
Strahlenther Onkol; 1995 Nov; 171(11):615-21. PubMed ID: 7502224
[TBL] [Abstract][Full Text] [Related]
37. Large cell/anaplastic medulloblastoma is associated with poor prognosis-a retrospective analysis at a single institute.
Huang PI; Lin SC; Lee YY; Ho DM; Guo WY; Chang KP; Chang FC; Liang ML; Chen HH; Liu YM; Yen SH; Wong TT; Chen YW
Childs Nerv Syst; 2017 Aug; 33(8):1285-1294. PubMed ID: 28488086
[TBL] [Abstract][Full Text] [Related]
38. Medulloblastoma: experience of a single institution.
Wolff JE; Huettermann U; Ritter J; Straeter R; Palm D; Ruebe C; Kraehling KH; Jürgens H
Klin Padiatr; 1998; 210(4):234-8. PubMed ID: 9743958
[TBL] [Abstract][Full Text] [Related]
39. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
[TBL] [Abstract][Full Text] [Related]
40. M1 Medulloblastoma: high risk at any age.
Sanders RP; Onar A; Boyett JM; Broniscer A; Morris EB; Qaddoumi I; Armstrong GT; Boop FA; Sanford RA; Kun LE; Merchant TE; Gajjar A
J Neurooncol; 2008 Dec; 90(3):351-5. PubMed ID: 18704266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
